ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 67 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 3.62 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $26,341 | -26.8% | 49,700 | 0.0% | 0.00% | -33.3% |
Q3 2022 | $36,000 | -36.8% | 49,700 | 0.0% | 0.00% | -25.0% |
Q2 2022 | $57,000 | -44.1% | 49,700 | 0.0% | 0.00% | -20.0% |
Q1 2022 | $102,000 | -28.7% | 49,700 | 0.0% | 0.01% | -37.5% |
Q4 2021 | $143,000 | -32.2% | 49,700 | 0.0% | 0.01% | -33.3% |
Q3 2021 | $211,000 | -19.8% | 49,700 | 0.0% | 0.01% | -29.4% |
Q2 2021 | $263,000 | +13.9% | 49,700 | 0.0% | 0.02% | +6.2% |
Q1 2021 | $231,000 | +40.9% | 49,700 | 0.0% | 0.02% | +23.1% |
Q4 2020 | $164,000 | -0.6% | 49,700 | 0.0% | 0.01% | -31.6% |
Q3 2020 | $165,000 | -88.9% | 49,700 | -88.8% | 0.02% | -93.4% |
Q2 2020 | $1,490,000 | -3.2% | 442,104 | +9.9% | 0.29% | -34.0% |
Q1 2020 | $1,540,000 | -36.6% | 402,212 | 0.0% | 0.44% | +115.3% |
Q4 2019 | $2,429,000 | -20.1% | 402,212 | 0.0% | 0.20% | -24.9% |
Q3 2019 | $3,041,000 | -45.4% | 402,212 | -2.2% | 0.27% | -48.8% |
Q2 2019 | $5,572,000 | +4253.1% | 411,212 | +1635.1% | 0.52% | +4275.0% |
Q1 2019 | $128,000 | +82.9% | 23,700 | 0.0% | 0.01% | +71.4% |
Q4 2018 | $70,000 | -63.7% | 23,700 | 0.0% | 0.01% | -56.2% |
Q3 2018 | $193,000 | +69.3% | 23,700 | +74.3% | 0.02% | 0.0% |
Q3 2017 | $114,000 | – | 13,600 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 507,191 | $5,107,000 | 0.50% |
Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |